-
AstraZeneca plans $15 B investment in China to expand medicines manufacturing and R&D
30 Jan 2026 23:25 GMT
… Chinese innovation to the world through our partnerships with leading biotechs … in Beijing and Shanghai, … Beijing, which provide high-quality medicines to patients in China and 70 markets … investments will grow the Company’s highly skilled workforce in China …
-
How China rewrote the rules of drug innovation
30 Jan 2026 23:45 GMT
… Beijing five to seven years later. This “China-Last” penalty rendered Chinese … investment.
State-backed funds co-invested alongside private venture capital, with biotech … healthcare, industry, and science ministries.
China’s domestic market is hypercompetitive …
-
Epidemiology and Antibiotic Resistance of Foodborne Diseases Among Children in Shanghai: A Four-Year Surveillance Study, 2021–2024
30 Jan 2026 23:54 GMT
… (EAEC) were purchased from Beijing Zhuocheng Huisheng Biotechnology Co. Ltd.2 Primer … poisoning, which results from toxins produced by pathogens; infections, which occur … outpatients through active surveillance in Shanghai, China, 2012-2016: a cross- …
-
Xi Jinping says 'epoch-making technological transformation' of AI can change the human race - but unsurprisingly wants Chinese firms to lead the way
30 Jan 2026 22:37 GMT
… comparable to quantum computing and biotechnology, and likened it to … Over a year ago, Chinese AI company DeepSeek released a large … , features and guidance your business needs to succeed!
By … existing infrastructure.
This suggests Beijing’s approach may focus …
-
STAT+: AstraZeneca looks to China for obesity drug candidates
30 Jan 2026 20:03 GMT
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Oh, hi. Today, we discuss delays in the launch of TrumpRx. Also, Sanofi is deprioritizing its mRNA flu vaccine.
The need-to-know …
-
MYC Targeting Therapies Market Research Report 2026-2030, Profiles of Genetic Leap, Curigin, IDP Pharma, Incurix, Omega, Panavance, Peptomyc, Suzhou Kintor, Wayfinder Biosciences, WebenPharma - ResearchAndMarkets.com
30 Jan 2026 18:04 GMT
… Clinical Trials Insight by Company, Country, Indication … for partnership or investment.
This report provides … concept datasets.
The investors, partners, and competitors … SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2026 …
-
AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
30 Jan 2026 16:45 GMT
… invest further into China’s biotechnology industry into action, striking … vast ecosystem of biotechs quickly developing therapies … or on the market. More than 60 … company had formed collaborations with Regeneron Pharmaceuticals and China-based biotech …
-
Pentagon Raises Alarm Over China’s Military-Civil Fusion Strategy
30 Jan 2026 17:06 GMT
… this doctrine is already reshaping Beijing’s policies, from technology … warfare, aligning all of Chinese society, including industry, infrastructure, technology, and … highlights China’s growing emphasis on AI, semiconductors, and biotech, technologies …
-
How AstraZeneca is Advancing Treatment Discovery in China
30 Jan 2026 16:40 GMT
… China’s advanced science in these fields, the investment … also working with leading Chinese biotechs including AbelZeta, CSPC, … Bio, bringing Chinese innovation to global markets through strategic … China, marking a major milestone in the company’ …
-
Astra Signs Obesity Drug Deal in China Worth Up to $18.5 Billion
30 Jan 2026 16:40 GMT
… Plc agreed to pay Chinese company CSPC Pharmaceutical Group Ltd. … the growing weight-loss market.
The agreement will see … in China, where Soriot separately announced $15 billion in investment … an obesity pill from Chinese biotech Eccogene, and is also …